• Mira Smart Conferencing
  • Home
  • Table of Contents
  • Advanced Search
 
Advanced Search

Browse All

Current Filters

CLEAR FILTER x

TITLE

Author Institution:

  • Beth Israel Deaconess Medical Center/Harvard Medical School, Boston, MA

Filter

Partial Search: Partial searches may be entered manually by pressing enter in the filter input field.
Author Filter: Selecting one or more Authors from the Author drop down list will filter results by Author last name(s) only.

Displaying 1 - 4 of 4

  • Page:
  • 1

Effectiveness and Safety of Ravulizumab in Generalized Myasthenia Gravis (gMG): Updated Analysis from a Global Registry

Author:Narayanaswami, Pushpa   Pulley, Michael   Macwan, Samir   Winkley, James   Zeinali, Lida   Liu, Chuang   Juel, Vern   Tandan, Rup   Sacca, Francesco   Gordon, Andrew   Howard, James   

Session Name:P1: Neuromuscular and Clinical Neurophysiology (EMG): Myasthenia Gravis 1  

Topic:Neuromuscular and Clinical Neurophysiology (EMG)  

Program Number:P1.014  

Author Institution:Beth Israel Deaconess Medical Center/Harvard Medical School, Boston, MA  University of Florida, Jacksonville, FL  Eisenhower Health Center, Rancho Mirage, CA  Baptist Health Medical Group Neurology, Lexington, KY  Alexion, AstraZeneca Rare Disease, Mississauga, ON, Canada  Alexion, AstraZeneca Rare Disease, Baar, Switzerland  Duke University, Durham, NC  University of Vermont Medical Center, Burlington, VT  University of Naples Federico II, Napoli, Italy  Northwest Neurology, Ltd., Lake Barrington, IL  The University of North Carolina at Chapel Hill School of Medicine, Chapel Hill, NC  

  • View Abstract
  • View Disclosure

Acute Hyperglycemia Is Associated With Cognitive Impairment Following Spontaneous Intracerebral Hemorrhage

Author:Das, Alvin   Heistand, Elizabeth   Lioutas, Vasileios-Arsenios   Fehnel, Corey   Yoon, Jason   Kumar, Sandeep   Regenhardt, Robert   Gurol, M. Edip   Ngo, Long   Benitez, Bruno   Selim, Magdy   

Session Name:P5: Cerebrovascular Disease and Interventional Neurology: Neurovascular Conditions and Rare Strokes Etiologies 1  

Topic:Cerebrovascular Disease and Interventional Neurology  

Program Number:P5.002  

Author Institution:Beth Israel Deaconess Medical Center/Harvard Medical School, Boston, MA  Massachusetts General Hospital/Harvard Medical School, Boston, MA  

  • View Abstract
  • View Disclosure

Change in Concomitant Immunosuppressive Therapies for Generalized Myasthenia Gravis in Patients Receiving Complement C5 Inhibitor Therapies: A Retrospective Analysis of Registry Data

Author:Nowak, Richard   Habib, Ali   Scheiner, Christopher   Zeinali, Lida   Pulley, Michael   Liu, Chuang   Gordon, Andrew   Narayanaswami, Pushpa   

Session Name:P7: Neuromuscular and Clinical Neurophysiology (EMG): Neuromuscular Junction Disorders 1  

Topic:Neuromuscular and Clinical Neurophysiology (EMG)  

Program Number:P7.028  

Author Institution:Yale School of Medicine, New Haven, CT  University of California, Irvine, Irvine, CA  University of Tennessee Medical Center, Knoxville, TN  Alexion, AstraZeneca Rare Disease, Mississauga, ON, Canada  University of Florida, Jacksonville, FL  Alexion, AstraZeneca Rare Disease, Baar, Switzerland  Northwest Neurology, Ltd., Lake Barrington, IL  Beth Israel Deaconess Medical Center/Harvard Medical School, Boston, MA  

  • View Abstract
  • View Disclosure

Evaluation of the Indirect and Nonmedical Impacts of Generalized Myasthenia Gravis on Patients and Caregivers

Author:Gwathmey, Kelly   Yee, Karen   Foss, Allison   Ramirez, Christina   Sullivan, Jamie   dosReis, Susan   Thiele, Craig   Schwartz, Taylor   Betor, Nicole   Hunt, Olivia   Rebeira, Mayvis   Narayanaswami, Pushpa   

Session Name:P9: Neuromuscular and Clinical Neurophysiology (EMG): Preclinical Studies, Drug Safety, and Health Economics  

Topic:Neuromuscular and Clinical Neurophysiology (EMG)  

Program Number:P9.032  

Author Institution:VCU Health, Richmond, VA  Alexion, AstraZeneca Rare Disease, Boston, MA  Myasthenia Gravis Association, Kansas City, MO  Patient Consultant, Rogers, AR  The EveryLife Foundation for Rare Diseases, Washington, DC  University of Maryland School of Pharmacy, Baltimore, MD  Health Management Associates (subcontractor), Dayton, OH  Avalere, Washington, DC  Alexion, AstraZeneca Rare Disease, Mississauga, ON, Canada  Beth Israel Deaconess Medical Center/Harvard Medical School, Boston, MA  

  • View Abstract
  • View Disclosure

Displaying 1 - 4 of 4

  • Page:
  • 1

© 2015 Mira Smart Conference | http://www.mirasmart.com